TD Private Client Wealth
GH icon

TD Private Client Wealth’s Guardant Health GH Stock Holding History

TD Private Client Wealth’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$178 Buy
+1
New +$163 ﹤0.01% 1720
2022
Q2 		– Sell
-6
Closed -$397 – 1250
2022
Q1 		$397 Buy
+6
New +$411 ﹤0.01% 1246

Other funds holding GH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

TD Private Client Wealth's GH Position: Q3 2026 in Review

TD Private Client Wealth opened a new position in Guardant Health (GH) in Q3 2026: 1 share worth $178. The stake represents ﹤0.01% of the portfolio and ranks #1720 among its holdings. This is a return to the name: TD Private Client Wealth previously reported a position in GH as recently as Q1 2022.

TD Private Client Wealth first reported a position in GH in Q1 2022 and has held it in 2 quarters since. The position peaked at $397 in Q1 2022. 511 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • TD Private Client Wealth held 1 share of Guardant Health worth $178 as of Q3 2026.
  • Guardant Health was a new TD Private Client Wealth position in Q3 2026.
  • Guardant Health made up ﹤0.01% of TD Private Client Wealth's portfolio in Q3 2026, its #1720 holding.
  • TD Private Client Wealth first reported a position in Guardant Health in Q1 2022 and has held it in 2 quarters since.
  • TD Private Client Wealth's Guardant Health position peaked at $397 in Q1 2022.
  • 511 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on TD Private Client Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.